Marijuana in Combination With Opioids in Palliative and Hospice Patients
Status:
Enrolling by invitation
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
Study Objectives: Primary reduction of pain and reduction in overall opioid utilization.
Secondary improvement in overall patient well being, weight stabilization with increased
appetite, improved oxygen saturation, improvement or prevention of nausea and vomiting.
Study Rationale: To determine optimum use and dosing of medical marijuana (CBD:THC) for pain
and symptom management.
Study Population: This study specifically will enroll cancer and non-cancer patients as a
primary diagnosis suffering from pain and having a terminal illness (defined as having less
than 6 months to live) requiring end of life care.